![Pharmaceuticals policy / Pharmacy / Counterfeit consumer goods / Clinical pharmacology / Counterfeit medications / Food and Drug Administration / Medical prescription / Serial number / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Health Pharmaceuticals policy / Pharmacy / Counterfeit consumer goods / Clinical pharmacology / Counterfeit medications / Food and Drug Administration / Medical prescription / Serial number / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Health](https://www.pdfsearch.io/img/605b1849b98c2585480bc85b2356b4b0.jpg) Date: 2014-02-26 09:35:58Pharmaceuticals policy Pharmacy Counterfeit consumer goods Clinical pharmacology Counterfeit medications Food and Drug Administration Medical prescription Serial number Pharmaceutical industry Pharmaceutical sciences Pharmacology Health | | Testimony before the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations United States House of Representatives February 27, 2014 Elizabeth Jungman, Director, Drug Safety and Innovation The PewAdd to Reading ListSource URL: docs.house.govDownload Document from Source Website File Size: 318,42 KBShare Document on Facebook
|